Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas

Area of Science:

• Hepatobiliary Surgery
• Oncology
• Endocrinology

Background:

• Estrogen receptors (ERs) are implicated in various cancers.
• Their role in hepatocellular carcinoma (HCC) remains unclear.
• Understanding ER status may inform treatment strategies for HCC.

Purpose of the Study:

• To investigate the presence and significance of estrogen receptors (ERs) in hepatocellular carcinoma (HCC).
• To determine if ER status correlates with clinicopathological features and patient outcomes in HCC.
• To evaluate the potential role of ERs in the biology of HCC.

Main Methods:

• Assay of cytosolic estrogen receptors (ERs) in 66 HCC patients undergoing radical hepatic resection.
• Analysis of preoperative clinical and laboratory data.
• Comparison of histopathological findings, tumor recurrence, and survival rates between ER-positive and ER-negative groups.

Main Results:

• Twenty-six out of 66 patients had detectable ERs in HCC cytosol.
• No significant differences were observed in clinical, laboratory, or histopathological data between ER-positive and ER-negative groups.
• Tumor recurrence and long-term survival rates were identical in both groups, despite a higher incidence of large tumors and major resections in the ER-negative group.

Conclusions:

• The presence or absence of ERs in human HCC does not appear to correlate with biologic or pathologic characteristics.
• The findings suggest ERs may not be a significant prognostic factor in HCC.
• Further research is needed to fully elucidate the role of ERs in human HCC.